Clinical Trials Logo

Antibiotic Resistant Strain clinical trials

View clinical trials related to Antibiotic Resistant Strain.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06314399 Not yet recruiting - Clinical trials for Antibiotic Resistant Strain

Predictive Factors Associated to Bile Cultures and Antibiogram Resistance in Patients With Laparoscopic Cholecystectomy

BACILO
Start date: April 1, 2024
Phase:
Study type: Observational

The BACILO study was designed with the objective of having robust data on local epidemiological bacterial colonisation information on bile cultures with patients taken to laparoscopic cholecystectomy in our institution to find which predictive factors are associated with culture positivity and antibiotic resistance patterns. Secondary endpoints include evaluating demographical, clinical and surgical variables and establishing comparison between both positive and negative bile cultures and between antibiotic sensitive and resistant microorganism strain isolations.

NCT ID: NCT06262009 Not yet recruiting - Clinical trials for Antibiotic Resistant Strain

Dynamics of AMR Spread, Persistence and Evolution Between Humans, Animals and Their Environment

Dyaspeo
Start date: September 2024
Phase:
Study type: Observational

Humans in contact with animals such as dog owners, may be at risk of antimicrobial resistance (AMR) acquisition. This is the central issue to be investigated in DYASPEO

NCT ID: NCT04795518 Not yet recruiting - Clinical trials for Antibiotic Resistant Strain

The Pattern of Antibiotic Prescription for Children Among a Group of Pediatric Dentists.

Start date: June 1, 2021
Phase:
Study type: Observational

The aim of this study is to determine the pattern of antibiotic prescription for children among a group of pediatric dentists

NCT ID: NCT04593368 Not yet recruiting - Clinical trials for Antibiotic Resistant Strain

Fecal Microbiome Transplantation (FMT) in Pediatric Patients Colonized With Antibiotic-resistant Pathogens Before Hematopoietic Stem Cell Transplantation (HSCT)

FMT-HSCT
Start date: December 15, 2020
Phase: Phase 2
Study type: Interventional

a clinical trial designed to prospectively assess the safety and effectiveness of fecal microbiota transplantation (FMT) prior to allogeneic hematopoietic stem-cell translation (HSCT) in patients contaminated with antibiotic-resistant pathogens (ARP)

NCT ID: NCT04269174 Not yet recruiting - Clinical trials for Antibiotic Resistant Strain

The Utility of Biofire Filmarray in Evaluation of Entero Pathogens Triggers in Patients With Chronic Diarrhea

Start date: February 2020
Phase:
Study type: Observational

Chronic diarrhea is a common condition and a key symptom in many disorders. It is a major cause of morbidity and mortality worldwide and one of the most common reasons for referral to a gastroenterology clinic.The prevalence varies depending on population and the definition of diarrhea used. It affects approximately 5% of the population at any given point in time, although the exact prevalence is unknown. Diarrhea is associated with 4 pathophysiological mechanisms: osmotic, secretory, exudative and altered motility. It is more useful to classify patients presenting with symptoms of diarrhea according to ''functional'' or ''organic'' characteristics. It is usually difficult to make a reliable differentiation between organic and functional causes in patients with chronic diarrhea based only on history and physical examination . The standard evaluation of patients with chronic diarrhea that begins with a detailed history, a careful physical examination and then basic diagnostic tests is critical for optimal treatment and prevention. Initially, thought needs to exclude several other possibilities as (a) fecal incontinence masquerading as diarrhea, (b) iatrogenic diarrhea due to drugs, surgery, or therapeutic radiation, (c) chronic infections, and (d) irritable bowel syndrome with diarrhea (IBS-D). The detection of a broad array of potentially offending agents has traditionally required a combination of microbiologic approaches, including bacterial culture, antigen detection, microscopy, and polymerase chain reaction (PCR). The new multiplex PCR-based panels have several advantages over conventional methods including (i) reduced sample volume requirements, (ii) broad coverage without the need to select specific tests, (iii) enhanced ability to detect coinfections (iv) increased sensitivity and specificity as high as 97-100% and (v) higher throughput.The food and drug administration (FDA) cleared and recommended the use of FilmArray GI panel (BioFire Diagnostics), which targets 22 analytes (bacteria with bacterial toxin, viruses, and parasites)